Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

John Howe, PhD

Merck and Co.

Disclosure(s): Merck & Co Inc: Employee, Stocks/Bonds

Poster(s):

153 - Molnupiravir Exhibits a High Barrier to the Development of SARS-CoV-2 Resistance in vitro
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET